Cases

Search for a case

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Cases

July 12, 2022

Sharps Compliance Corp. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sharps Compliance Corp. (“Sharps Compliance” or the “Company”) (NASDAQ: SMED) in connection with the proposed tender offer for the Company by an affiliate of Aurora Capital Partners. Under the terms of the merger agreement, the Company’s shareholders will receive $8.75 in cash for each share of Sharps Compliance common stock owned.

Join Case →

July 11, 2022

La Jolla Pharmaceutical Company Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of La Jolla Pharmaceutical Company (“La Jolla” or the “Company”) (NASDAQ: LJPC) in connection with the proposed acquisition of the Company by Innoviva, Inc. (NASDAQ: INVA) via tender offer. Under the terms of the merger agreement, the Company’s shareholders will receive $6.23 in cash for each share of La Jolla common stock owned.

Join Case →

July 7, 2022

Meridian Bioscience, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Meridian Bioscience, Inc. (“Meridian” or the “Company”) (NASDAQ: VIVO), in connection with the proposed acquisition of the Company by SD Biosensor, Inc. (“SDB”) and SJL Partners LLC (“SJL”). Under the merger agreement, the Company’s shareholders will receive $34.00 in cash for each share of Meridian stock owned, leaving SDB owning approximately 60% and SJL owning approximately 40% of Meridian.

Join Case →

July 6, 2022

Resolute Forest Products Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Resolute Forest Products Inc. (“Resolute” or the “Company”) (NYSE: RFP) in connection with the proposed acquisition of the Company by The Paper Excellence Group, through its wholly-owned subsidiary Domtar Corporation (“Domtar”). The transaction will be carried out by way of a merger of Resolute with a newly created subsidiary of Domtar, providing for conversion of each share of Resolute common stock into the right to receive $20.50 per share, together with a Contingent Value Right (“CVR”) entitling the holder to a share of future softwood lumber duty deposit refunds.

Join Case →

July 5, 2022

Syros Pharmaceuticals, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Syros Pharmaceuticals, Inc. (“Syros” or the “Company”)(NASDAQ: SYRS) in connection with the proposed merger of the Company with TYME Technologies, Inc. (“TYME”) (NASDAQ: TYME). Under the terms of the merger agreement, the two companies will combine their businesses in an all-stock transaction that will result in one combined entity that will continue to trade publicly on the Nasdaq under the ticker symbol “SYRS.”

Join Case →

June 27, 2022

USA Truck, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of USA Truck, Inc. (“USA Truck” or the “Company”) (NASDAQ:USAK), in connection with the proposed acquisition of the Company by DB Schenker. Under the terms of the merger agreement, the Company’s shareholders will receive $31.72 in cash for each share of USA Truck common stock owned.

Join Case →

June 27, 2022

Epizyme, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Epizyme, Inc. (“Epizyme” or the “Company”) (NASDAQ:EPZM), in connection with the proposed acquisition of the Company by Ipsen S.A.(Euronext: IPN; ADR: IPSEY) via tender offer. Under the terms of the merger agreement, the Company’s shareholders will receive $1.45 in cash, plus one contingent value right (CVR) for each share of Epizyme common stock owned.

Join Case →

June 27, 2022

Radius Health, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Radius Health, Inc. (“Radius Health” or the “Company”)(NASDAQ: RDUS), in connection with the proposed acquisition of the Company by Gurnet Point Capital and Patient Square Capital via tender offer. Under the terms of the merger agreement, the Company’s shareholders will receive $ 10.00 per share plus a Contingent Value Right (CVR) of$1.00 per share payable upon TYMLOS net sales reaching $300 million during any consecutive 12-month period prior to December 31, 2025.

Join Case →

June 24, 2022

Zendesk, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Zendesk, Inc. (“Zendesk” or the “Company”) (NYSE:ZEN), in connection with the proposed acquisition of the Company by investment firms Permira and Hellman & Friedman LLC. Under the terms of the merger agreement, the Company’s shareholders will receive $77.50 in cash for each share of Zendesk common stock owned.

Join Case →

We will fight for you and have your back no matter what. Join the tens of thousands of people we’ve helped.

Cases

Search for a case

Cases

Sharps Compliance Corp. Investigation

La Jolla Pharmaceutical Company Investigation

Meridian Bioscience, Inc. Investigation

Resolute Forest Products Inc. Investigation

Syros Pharmaceuticals, Inc. Investigation

USA Truck, Inc. Investigation

Epizyme, Inc. Investigation

Radius Health, Inc. Investigation

Zendesk, Inc. Investigation

Where to find us?

new york

california

georgia

NEW JERSEY